[Nle20] H4 peptide (16−23) is a peptide with strong inhibitory activity against histone methyltransferase SETD8 ( K d =0.14 μM), which inhibits SETD8 's methylation of histone H4 by competing with SETD8 's substrate binding site. [Nle20] H4 peptide (16−23) can be used as a lead compound for anticancer therapy.
Products | Products > Peptides | Products > Disease Areas > Cancer | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Histone Methyltransferase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.